Doxylamine is one of the most well-studied medications used during pregnancy, and the safety data is reassuring. It holds FDA Pregnancy Category A status, the highest safety rating available, meaning well-controlled studies have failed to show any risk to the fetus in any trimester. Combined with vitamin B6 (pyridoxine), it is the only FDA-approved treatment for nausea and vomiting of pregnancy.
What the Safety Data Shows
Doxylamine has been used by pregnant women since 1956, when the FDA first approved it (combined with vitamin B6) under the brand name Bendectin. That original product was taken by millions of women over nearly three decades. It was pulled from the market in 1983, not because of any safety problem, but because the manufacturer couldn’t afford the rising cost of defending against lawsuits that were ultimately unsuccessful. The FDA publicly stated twice, in 1983 and again in 1999, that the drug had not been withdrawn due to safety or effectiveness concerns.
In 2013, the same combination was reapproved under the brand name Diclegis (now also available as Bonjesta). The decades of accumulated safety data are precisely what earned it Category A status, a designation very few medications achieve. A large meta-analysis looking specifically at doxylamine exposure found no meaningful increase in birth defects: the summary odds ratio was 1.07, with a confidence interval of 0.93 to 1.23. In plain terms, children exposed to doxylamine in the womb had essentially the same rate of congenital malformations as those who weren’t exposed.
How It Works Against Nausea
Doxylamine is a first-generation antihistamine. It blocks histamine receptors throughout the body, including in the brain’s vomiting center. It also dampens signals from the vestibular system (your inner-ear balance center) and the chemoreceptor trigger zone, both of which contribute to the nausea and vomiting that many women experience in pregnancy. These same properties are why it also causes drowsiness, which is why doxylamine doubles as a sleep aid outside of pregnancy.
When paired with vitamin B6, the two ingredients target nausea through complementary pathways. Clinical trials showed the combination reduced nausea and vomiting symptom scores significantly more than placebo, and the American College of Obstetricians and Gynecologists (ACOG) recommends vitamin B6 with or without doxylamine as a first-line treatment.
Typical Dosing Schedule
The prescription form (Diclegis) contains 10 mg of doxylamine and 10 mg of vitamin B6 per tablet in a delayed-release formulation. The recommended starting dose is two tablets at bedtime. If nausea persists into the afternoon the next day, a third tablet is added in the morning. If symptoms are still not controlled, the dose increases to four tablets daily: one in the morning, one in the mid-afternoon, and two at bedtime. Four tablets per day is the maximum.
Many women use an over-the-counter approach instead, combining a doxylamine sleep aid with a separate vitamin B6 supplement. This is where an important product distinction matters.
Choosing the Right OTC Product
If you’re buying an over-the-counter version, you need Unisom SleepTabs specifically. These contain doxylamine succinate (25 mg per tablet). Other Unisom products, including SleepGels, SleepMinis, SleepMelts, and Unisom PM, contain a different antihistamine called diphenhydramine. Unisom PM also contains acetaminophen. These are not the same medication and are not what’s recommended for pregnancy nausea.
ACOG notes that half of a scored 25 mg SleepTab (providing 12.5 mg of doxylamine) can be used as a dose. Your provider can help you determine the right timing and frequency based on your symptoms.
Common Side Effects
The most common side effect is drowsiness, which is why the initial dose is taken at bedtime. Other typical effects include dry mouth, dry nose, and dry throat. These are generally mild and tend to be manageable for most women.
Less common but more serious side effects include difficulty urinating or painful urination. If you experience this, stop taking the medication and contact your healthcare provider. Overdose symptoms mirror the common side effects but in amplified form: excessive sleepiness, severe dry mouth, and urinary difficulty.
Because doxylamine causes sedation, it can affect alertness during the day, particularly at higher doses. Many women find that starting with the bedtime-only dose and adding daytime doses gradually helps them gauge how drowsy the medication makes them before driving or doing other tasks that require full attention.
Safety While Breastfeeding
Small occasional doses of doxylamine are not expected to cause adverse effects in breastfed infants. Larger doses or more prolonged use may cause drowsiness in the baby and could potentially decrease milk supply, especially before breastfeeding is well established. High-dose antihistamines given by injection have been shown to lower baseline prolactin levels in postpartum women, though the prolactin surge triggered by actual suckling doesn’t appear to be affected. Whether lower oral doses have the same impact on milk supply hasn’t been thoroughly studied, but prolactin levels in mothers with established lactation may not significantly affect their ability to breastfeed.